Therapeutic Efficacy, Radiotoxicity and Abscopal Effect of BNCT at the RA-3 Nuclear Reactor Employing Oligo-Fucoidan and Glutamine as Adjuvants in an Ectopic Colon Cancer Model in Rats

Boron neutron capture therapy (BNCT) is based on the preferential uptake of B-10 compounds by tumors, followed by neutron irradiation. The aim of this study was to assess, in an ectopic colon cancer model, the therapeutic efficacy, radiotoxicity, abscopal effect and systemic immune response associated with (BPA/Borophenylalanine+GB-10/Decahydrodecaborate)-BNCT (Comb-BNCT) alone or in combination with Oligo-Fucoidan (O-Fuco) or Glutamine (GLN), compared to the standard BPA-BNCT protocol usually employed in clinical trials. All treatments were carried out at the RA-3 nuclear reactor. Boron biodistribution studies showed therapeutic values above 20 ppm B-10 in tumors. At 7 weeks post-treatment, the ratio of tumor volume post-/pre-BNCT was significantly smaller for all BNCT groups vs. SHAM (p < 0.05). The parameter incidence of tumors that underwent a reduction to & LE;50% of initial tumor volume exhibited values of 62% for Comb-BNCT alone, 82% for Comb-BNCT+GLN, 73% for Comb-BNCT+O-Fuco and only 30% for BPA-BNCT. For BPA-BNCT, the incidence of severe dermatitis was 100%, whereas it was significantly below 70% (p & LE; 0.05) for Comb-BNCT, Comb-BNCT+O-Fuco and Comb-BNCT+GLN. Considering tumors outside the treatment area, 77% of Comb-BNCT animals had a tumor volume lower than 50 mm(3) vs. 30% for SHAM (p & LE; 0.005), suggesting an abscopal effect of Comb-BNCT. Inhibition of metastatic spread to lymph nodes was observed in all Comb-BNCT groups. Considering systemic aspects, CD8(+) was elevated for Comb-BNCT+GLN vs. SHAM (p & LE; 0.01), and NK was elevated for Comb-BNCT vs. SHAM (p & LE; 0.05). Comb-BNCT improved therapeutic efficacy and reduced radiotoxicity compared to BPA-BNCT and induced an immune response and an abscopal effect.

Automated summary

Boron neutron capture therapy (BNCT) is a treatment method that utilizes the preferential uptake of B-10 compounds by tumors followed by neutron irradiation. This study aimed to evaluate the therapeutic efficacy, radiotoxicity, abscopal effect, and systemic immune response of Comb-BNCT alone or in combination with Oligo-Fucoidan (O-Fuco) or Glutamine (GLN) compared to the standard BPA-BNCT protocol. The results showed that Comb-BNCT had higher therapeutic values and reduced radiotoxicity compared to BPA-BNCT, and also induced an immune response and abscopal effect.